×

Do you want to link to other external websites and leave Amgen.com.au?

You are now leaving Amgen Australia’s website. Amgen Australia takes no responsibility for, and exercises no control over the organisation, views, or information contained on the server or site which you will be accessing. The information contained might not comply with the Australian regulatory environment.

×

Do you want to link to other websites and leave Amgen.com.au?

You are now leaving Amgen Australia’s website. Amgen Australia takes no responsibility for the information contained on the Amgen international server or site which you will be accessing. The information you are about to access may not comply with the Australian regulatory environment.

PRODUCT INFORMATION

Product Information

Refer to approved product information for complete indication.

Aranesp® (darbepoetin alfa)

Aranesp® Product Information

BLINCYTO® (blinatumomab)

BLINCYTO® Product Information

IMLYGIC (talimogene laherparepvec)

IMLYGIC Product Information

KYPROLIS® (carfilzomib)

KYPROLIS® Product Information

Neulasta® (pegfilgrastim)

Neulasta® Product Information

NEUPOGEN® (filgrastim)

NEUPOGEN® Product Information

Nplate® (romiplostim)

Nplate® Product Information

Prolia® (denosumab)

Prolia® Product Information

RISTEMPA® (pegfilgrastim)

RISTEMPA® Product Information

Repatha (evolocumab)

Repatha Product Information

Sensipar® (cinacalcet HCl)

Sensipar® Product Information

Vectibix® (panitumumab)

Vectibix® Product Information

XGEVA® (denosumab)

XGEVA® Product Information